Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymyxin B vs colistin for carbapenem-resistant Gram-negative infections
TCTR20250206010Phase 4Not yet recruiting
- Sponsor
- No
- Start
- Apr 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Carbapenem-resistant Gram-negative bacterial infection (CRGNB) comparing Polymyxin B with Colistin (2 arms). Planned start Apr 2025; status: not yet recruiting.
02
Drugs
polymyxin Bcolistin
03
Conditions
Carbapenem-resistant Gram-negative bacterial infection (CRGNB)
Beyond the preview
Go deeper on TCTR20250206010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250206010.